GlassScriptPhysician profile
Gregory Lynn Watson
NPI 1770676793
$986.09
in general payments reported to CMS, 2019-2025
21 companies · $33.68 in 2025
The $33.68 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $207 · 2021: $67.07 · 2022: $77.54 · 2023: $174 · 2024: $201 · 2025: $33.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $176.12 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $146.99 | 2019-2023 | |
| Intuitive Surgical, INC. | $124.24 | 2020 | |
| Microline Surgical INC | $81.88 | 2022-2024 | |
| Boston Scientific Corporation | $74.77 | 2019 | |
| Zimmer Biomet Holdings, INC. | $65.86 | 2020 | |
| Depuy Synthes Sales INC. | $38.81 | 2019-2025 | Matrixrib |
| Ethicon US, LLC | $37.49 | 2021-2024 | Echelon Flex, Echelon Circular |
| Davol INC. | $36.22 | 2021-2024 | |
| Becton, Dickinson and Company | $26.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2021 | |
| Dilon Technologies, INC. | $20.91 | 2023 | Hemoblast Bellows |
| Shire North American Group INC | $18.59 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.52 | 2025 | |
| Merck Sharp & Dohme LLC | $16.54 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $14.59 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Covidien LP | $14.41 | 2019 | |
| Innocoll Pharmaceuticals Limited | $13.49 | 2022 | |
| Cook Medical LLC | $12.37 | 2019 | |
| Haemonetics Corporation | $11.78 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.